THE Food and Drug Administration (FDA) on Monday advised all retailers of medical devices to secure their license to operate (LTO) following the full implementation of FDA Circular 2021-021.
The circular, issued on Oct. 7, 2021, aims to provide specific guidelines on the licensing of retailers of medical devices supplementing the provisions of the Department of Health Administrative Order (AO) 2020-0017. It took effect on Dec. 18, 2021 after its publication in a newspaper of general circulation on Dec. 3, 2021.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.